Life sciencesAlternativesContinental EuropeFranceInvestmentOffice
16 Nov 2022 15:15 GMT | by Francesco Magon
The biotech occupier will stay in the property for a further five years
Casino completes restructuring and names new leadership team
Dii files for insolvency in liquidity squeeze
Corem disposes of €67m Swedish assets
Chalegrove wins appeal for 55-storey Canary Wharf resi tower
CBRE IM raises €750m in green bond issue
LondonMetric declines to table competing offer for UKCM
CitizenM owners explore €4bn+ sale
Knight Frank appoints new UK head of capital markets
Microsoft weighs HQ options after terminating lease
Can Liverpool’s science and creative sectors fuel the city’s renaissance?